Henry Schein completed the acquisition of Acentus.

Henry Schein, a provider of healthcare products and services, completed the acquisition of Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors. “Henry Schein continues to expand upon our national homecare solutions platform to effectively address the evolving needs of our customers, which includes clinics, physician practices, health systems, and patients receiving care at home. The acquisition of Acentus represents an important step towards strengthening our position within the home medical supply market. By directly delivering CGM products to patients’ homes, we are enhancing our ability to serve our valued customers and drive growth,” Stanley M. Bergman, Henry Schein Chairman of the Board and Chief Executive Officer.